Tristetraprolin Posttranscriptionally Downregulates TRAIL Death Receptors

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) has attracted attention as a potential candidate for cancer therapy. However, many primary cancers are resistant to TRAIL, even when combined with standard chemotherapy. The mechanism of TRAIL resistance in cancer cells has not be...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Won Hyeok, Han, Myung Woul, Kim, Song Hee, Seong, Daseul, An, Jae Hee, Chang, Hyo Won, Kim, Sang Yoon, Kim, Seong Who, Lee, Jong Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465502/
https://www.ncbi.nlm.nih.gov/pubmed/32784606
http://dx.doi.org/10.3390/cells9081851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465502/
https://www.ncbi.nlm.nih.gov/pubmed/32784606
http://dx.doi.org/10.3390/cells9081851

Ejemplares similares